Combination drug therapy in the management of hypertension has been used for many
years. Recent recommendations of the Seventh Joint National Committee on Prevention …

Almost one billion individuals worldwide are currently estimated to be affected by
hypertension, or high blood pressure, with this figure predicted to rise to over 1.5 billion by …

The ultimate reason for lowering blood pressure (BP) is to reduce the morbidity and mortality
associated with hypertension. In clinical trials, antihypertensive therapy has been associated …

Hypertension incurs a significant healthcare burden in Asia-Pacific countries, which have
suboptimal rates of blood pressure (BP) treatment and control. A consensus meeting of …

Introduction It is paradoxical that there should be a very broad consensus that combination
therapy represents the way forward for the rational use of blood pressure lowering drugs in …

At all blood pressure (BP) levels> 115/75 mm Hg, the association between increasing BP
and increasing risk for cardiovascular (CV) events is strong, continuous, and independent of …

Monotherapy is able to normalize blood pressure in less than a quarter of patients with
hypertension. However, for a disease of multifactorial pathogenesis like essential …

In their recently released report, the Institute of Medicine (IOM) states that nearly one of
every three adults in the United States has hypertension. In their ''A Population-Based Policy …

Despite extensive debate about the first choice for treating essential hypertension,
monotherapy effectively normalizes blood pressure (BP) values in only a limited number of …

Current hypertension treatment guidelines recommend a goal of< 140/90mmHg for
population with uncomplicated hypertension and goals are even lower (< 130/80mmHg) for …